• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

应激性心肌病中的微血管功能与炎症激活

Microvascular function and inflammatory activation in Takotsubo cardiomyopathy.

作者信息

Solberg Ole Geir, Aaberge Lars, Bosse Gerhard, Ueland Thor, Gullestad Lars, Aukrust Pål, Stavem Knut

机构信息

Department of Cardiology, Oslo University Hospital, Oslo, Norway.

Department of Radiology, Oslo University Hospital, Oslo, Norway.

出版信息

ESC Heart Fail. 2023 Oct;10(5):3216-3222. doi: 10.1002/ehf2.14461. Epub 2023 Aug 3.

DOI:10.1002/ehf2.14461
PMID:37537779
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10567652/
Abstract

AIMS

The aim of this study was to determine microvascular function in the acute phase of Takotsubo syndrome (TTS) and to identify inflammatory mediators that could reflect TTS-induced pathology.

METHODS AND RESULTS

The study included 20 females [median age 65 years; interquarile range (IQR) = 58-70 years] with TTS according to the Mayo diagnostic criteria. During heart catheterization, we determined the index of microvascular resistance (IMR) and drew blood samples almost simultaneously from the aorta and coronary sinus. Cardiac magnetic resonance imaging (MRI) was done in the acute phase. We present descriptive coronary physiology and cardiac MRI data and compare inflammatory biomarkers between samples from the aorta, coronary sinus, and venous samples after 3 months using the Wilcoxon signed-rank test. For comparison, we also analysed the actual biomarkers in venous blood from 15 healthy female controls. A supplementary analysis explored Spearman's rank correlation between the inflammatory biomarkers, IMR, MRI data, and cardiac biomarkers. The median IMR was 16.5 mmHg·s (IQR = 10.5-28.2 mmHg·s), which was only slightly higher than that in the reference populations. Seven (35%) of the study subjects had IMR > 25 mmHg·s, suggesting a microvascular dysfunction. IMR was not affected by time from symptom onset. According to MRI, the apical region of the left ventricle was affected in 65% of the subjects. The median ejection fraction was 41% (IQR = 31-48%). Biomarker analyses revealed elevation of markers for extracellular matrix remodelling and fibrosis, inflammation, immune activation, and upstream inflammation as compared with healthy controls. Only the levels of interleukin (IL)-1 receptor antagonist and soluble T-cell immunoglobulin mucin domain-3 (sTIM-3) were higher in the coronary sinus than in the aorta. No variable was significantly correlated with IMR. The IL-6 level in the aorta was inversely correlated with the left ventricular ejection fraction. Growth differentiation factor-15, osteoprotegerin, and von Willebrand factor levels in both aorta and coronary sinus were positively correlated with N-terminal-pro-brain-natriuretic peptide, while the correlations of IL-6 and sTIM-3 with N-terminal-pro-brain-natriuretic peptide were restricted to the aorta and coronary sinus, respectively. While most of the markers were within normal limits after 3 months, matrix metalloproteinase-9 increased during follow-up to reach levels higher than those in the healthy controls.

CONCLUSION

The median IMR was only slightly elevated in this study, but about one-third of the patients had values indicating microvascular dysfunction. The present study supports the involvement of several inflammatory pathways in TTS, including monocyte/macrophage activation, with sTIM-3 as a potential novel marker.

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf5/10567652/f6595dfbfc7e/EHF2-10-3216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf5/10567652/f6595dfbfc7e/EHF2-10-3216-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5bf5/10567652/f6595dfbfc7e/EHF2-10-3216-g001.jpg
摘要

目的

本研究旨在确定应激性心肌病(TTS)急性期的微血管功能,并识别可反映TTS所致病理变化的炎症介质。

方法与结果

本研究纳入了20名符合梅奥诊断标准的女性患者[年龄中位数65岁;四分位间距(IQR)=58 - 70岁]。在心脏导管插入术期间,我们测定了微血管阻力指数(IMR),并几乎同时从主动脉和冠状窦采集血样。在急性期进行了心脏磁共振成像(MRI)检查。我们呈现了描述性的冠状动脉生理学和心脏MRI数据,并使用Wilcoxon符号秩检验比较了主动脉、冠状窦样本以及3个月后静脉样本之间的炎症生物标志物。为作比较,我们还分析了15名健康女性对照者静脉血中的实际生物标志物。一项补充分析探讨了炎症生物标志物、IMR、MRI数据和心脏生物标志物之间的Spearman等级相关性。IMR中位数为16.5 mmHg·s(IQR = 10.5 - 28.2 mmHg·s),仅略高于参考人群。7名(35%)研究对象的IMR > 25 mmHg·s,提示微血管功能障碍。IMR不受症状发作时间的影响。根据MRI检查,65%的研究对象左心室心尖区域受到影响。射血分数中位数为41%(IQR = 31 - 48%)。生物标志物分析显示,与健康对照者相比,细胞外基质重塑和纤维化、炎症、免疫激活以及上游炎症的标志物水平升高。仅白细胞介素(IL)-1受体拮抗剂和可溶性T细胞免疫球蛋白粘蛋白结构域-3(sTIM-3)在冠状窦中的水平高于主动脉。没有变量与IMR显著相关。主动脉中的IL-6水平与左心室射血分数呈负相关。主动脉和冠状窦中的生长分化因子-15、骨保护素和血管性血友病因子水平均与N末端脑钠肽前体呈正相关,而IL-6和sTIM-3与N末端脑钠肽前体的相关性分别仅限于主动脉和冠状窦。虽然大多数标志物在3个月后处于正常范围内,但基质金属蛋白酶-9在随访期间升高,达到高于健康对照者的水平。

结论

本研究中IMR中位数仅略有升高,但约三分之一的患者其值表明存在微血管功能障碍。本研究支持多种炎症途径参与TTS,包括单核细胞/巨噬细胞激活,sTIM-3作为一种潜在的新型标志物。

相似文献

1
Microvascular function and inflammatory activation in Takotsubo cardiomyopathy.应激性心肌病中的微血管功能与炎症激活
ESC Heart Fail. 2023 Oct;10(5):3216-3222. doi: 10.1002/ehf2.14461. Epub 2023 Aug 3.
2
Coronary microvascular dysfunction in Takotsubo syndrome and associations with left ventricular function.应激性心肌病的冠状动脉微血管功能障碍及其与左心室功能的关系。
ESC Heart Fail. 2023 Aug;10(4):2395-2405. doi: 10.1002/ehf2.14394. Epub 2023 May 22.
3
Angiography-derived index of microvascular resistance in takotsubo syndrome.Takotsubo 综合征的血管造影衍生微血管阻力指数。
Int J Cardiovasc Imaging. 2023 Jan;39(1):233-244. doi: 10.1007/s10554-022-02698-6. Epub 2022 Nov 7.
4
Coronary microvascular dysfunction in Takotsubo syndrome: an analysis using angiography-derived index of microcirculatory resistance.心肌梗死后应激性心肌病患者冠状动脉微血管功能障碍:采用微血管阻力指数分析的结果
Clin Res Cardiol. 2024 Dec;113(12):1629-1637. doi: 10.1007/s00392-023-02329-7. Epub 2023 Nov 20.
5
Coronary microvascular dysfunction in patients with heart failure with preserved ejection fraction.射血分数保留的心力衰竭患者的冠状动脉微血管功能障碍。
Am J Physiol Heart Circ Physiol. 2018 May 1;314(5):H1033-H1042. doi: 10.1152/ajpheart.00680.2017. Epub 2018 Feb 9.
6
Trans-Cardiac Gradient of Secretoneurin in Patients with Takotsubo Syndrome.心肌顿抑综合征患者心脏外分泌的脑肠肽转移梯度。
Cardiology. 2024;149(5):466-471. doi: 10.1159/000539094. Epub 2024 Apr 25.
7
Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure.正常受试者和心力衰竭患者中B型利钠肽与A型利钠肽分泌的定位及机制比较
Circulation. 1994 Jul;90(1):195-203. doi: 10.1161/01.cir.90.1.195.
8
Case Report: Acute Heart Failure Induced by the Combination of Takayasu's, Takotsubo and Coronary Vasospasm in an Elementary School Teacher-A Reaction to Return-to-Work Stress After COVID-19?病例报告:一名小学教师中由高安氏病、应激性心肌病和冠状动脉痉挛共同引发的急性心力衰竭——是对新冠疫情后重返工作岗位压力的一种反应?
Front Psychiatry. 2022 May 2;13:882870. doi: 10.3389/fpsyt.2022.882870. eCollection 2022.
9
Zumba-induced Takotsubo cardiomyopathy: a case report.尊巴引发的应激性心肌病:一例报告
J Med Case Rep. 2018 Jun 10;12(1):160. doi: 10.1186/s13256-018-1696-x.
10
Microvascular resistance of the culprit coronary artery in acute ST-elevation myocardial infarction.罪犯冠状动脉在急性 ST 段抬高型心肌梗死中的微血管阻力。
JCI Insight. 2016 May 5;1(6):e85768. doi: 10.1172/jci.insight.85768.

引用本文的文献

1
Assessment of Microvascular Function in Angina Pectoris by Angiography-Based Index of Microcirculation Resistance: A Meta-Analysis.基于血管造影术的微循环阻力指数评估心绞痛患者的微血管功能:一项荟萃分析
Rev Cardiovasc Med. 2025 Aug 25;26(8):25764. doi: 10.31083/RCM25764. eCollection 2025 Aug.
2
Validation of Takotsubo Syndrome Scoring System.Takotsubo综合征评分系统的验证
Diagnostics (Basel). 2025 May 23;15(11):1314. doi: 10.3390/diagnostics15111314.
3
Impact of Coronary Microvascular Dysfunction in Takotsubo Syndrome: Cause, Consequence or Both?

本文引用的文献

1
Cardiac remodeling secondary to chronic volume overload is attenuated by a novel MMP9/2 blocking antibody.新型 MMP9/2 阻断抗体可减轻慢性容量超负荷引起的心脏重构。
PLoS One. 2020 Apr 9;15(4):e0231202. doi: 10.1371/journal.pone.0231202. eCollection 2020.
2
Short- and Long-Term Prognosis of Patients With Takotsubo Syndrome Based on Different Triggers: Importance of the Physical Nature.基于不同触发因素的 Takotsubo 综合征患者的短期和长期预后:物理性质的重要性。
J Am Heart Assoc. 2019 Dec 17;8(24):e013701. doi: 10.1161/JAHA.119.013701. Epub 2019 Dec 13.
3
'Acute micro-coronary syndrome': detailed coronary physiology in a patient with Takotsubo cardiomyopathy.
冠状动脉微血管功能障碍在应激性心肌病中的作用:原因、后果还是两者皆有?
Rev Cardiovasc Med. 2024 May 11;25(5):163. doi: 10.31083/j.rcm2505163. eCollection 2024 May.
4
Is index of microvascular resistance of Sisyphean utility in Takotsubo syndrome?微血管阻力指数在应激性心肌病中是否无用?
ESC Heart Fail. 2024 Dec;11(6):4438-4440. doi: 10.1002/ehf2.14943. Epub 2024 Jul 14.
5
The role of inflammation in takotsubo syndrome: A new therapeutic target?炎症在应激性心肌病中的作用:一个新的治疗靶点?
J Cell Mol Med. 2024 Jun;28(12):e18503. doi: 10.1111/jcmm.18503.
6
2024 update in heart failure.2024年心力衰竭治疗进展
ESC Heart Fail. 2025 Feb;12(1):8-42. doi: 10.1002/ehf2.14857. Epub 2024 May 28.
7
Takotsubo Syndrome and Coronary Artery Disease: Which Came First-The Chicken or the Egg?应激性心肌病与冠状动脉疾病:孰先孰后——鸡还是蛋?
J Cardiovasc Dev Dis. 2024 Jan 26;11(2):39. doi: 10.3390/jcdd11020039.
8
ESCHF-23-00103R1 'Microvascular function and inflammatory activation in Takotsubo cardiomyopathy'.ESCHF - 23 - 00103R1“应激性心肌病中的微血管功能与炎症激活”
ESC Heart Fail. 2024 Apr;11(2):1279. doi: 10.1002/ehf2.14652. Epub 2024 Jan 1.
“急性微小冠状动脉综合征”:Takotsubo心肌病患者的详细冠状动脉生理学
BMJ Case Rep. 2019 Aug 28;12(8):e229618. doi: 10.1136/bcr-2019-229618.
4
Index of microvascular resistance to assess the effect of rosuvastatin on microvascular function in women with chest pain and no obstructive coronary artery disease: A double-blind randomized study.评估瑞舒伐他汀对胸痛且无阻塞性冠状动脉疾病女性微血管功能影响的微血管阻力指数:一项双盲随机研究。
Catheter Cardiovasc Interv. 2019 Nov 1;94(5):660-668. doi: 10.1002/ccd.28157. Epub 2019 Feb 21.
5
Tim-3 regulates inflammatory cytokine expression and Th17 cell response induced by monocytes from patients with chronic hepatitis B.Tim-3 调节慢性乙型肝炎患者单核细胞诱导的炎症细胞因子表达和 Th17 细胞反应。
Scand J Immunol. 2019 May;89(5):e12755. doi: 10.1111/sji.12755. Epub 2019 Mar 18.
6
Characterization of the Myocardial Inflammatory Response in Acute Stress-Induced (Takotsubo) Cardiomyopathy.急性应激性(应激性心肌病)心肌病中心肌炎症反应的特征
JACC Basic Transl Sci. 2018 Dec 31;3(6):766-778. doi: 10.1016/j.jacbts.2018.08.006. eCollection 2018 Dec.
7
Myocardial and Systemic Inflammation in Acute Stress-Induced (Takotsubo) Cardiomyopathy.急性应激诱发(心尖球囊样)心肌病中心肌和全身炎症。
Circulation. 2019 Mar 26;139(13):1581-1592. doi: 10.1161/CIRCULATIONAHA.118.037975.
8
Long-Term Prognosis of Patients With Takotsubo Syndrome.Takotsubo 综合征患者的长期预后。
J Am Coll Cardiol. 2018 Aug 21;72(8):874-882. doi: 10.1016/j.jacc.2018.06.016.
9
International Expert Consensus Document on Takotsubo Syndrome (Part I): Clinical Characteristics, Diagnostic Criteria, and Pathophysiology.国际 Takotsubo 综合征专家共识文件(第一部分):临床特征、诊断标准和病理生理学。
Eur Heart J. 2018 Jun 7;39(22):2032-2046. doi: 10.1093/eurheartj/ehy076.
10
Physically triggered takotsubo cardiomyopathy has a worse prognosis: Potential roles of systemic inflammation and coronary slow flow phenomenon.身体触发型应激性心肌病预后较差:全身炎症和冠状动脉慢血流现象的潜在作用。
Int J Cardiol. 2017 Sep 1;242:31-32. doi: 10.1016/j.ijcard.2017.03.082.